7th Jan 2011 16:45
The Directors/PDMR shareholding announcement released on 7 January at 16.12 pm under RNS No 1318Z should have been issued under the Company name of GlaxoSmithKline Plc and not under the Company name of GlaxoSmithKline Capital Plc
The announcement text is unchanged and is reproduced in full below.
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.50 per Ordinary share on 6 January 2011 through the Company's Share Reward Plan ("the Plan").
Mr A P Witty | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr J S Heslop | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr E J Gray | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain | Acquisition of 7 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman | Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas | Acquisition of 29 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr P J T Vallance | Acquisition of 13 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 7 January 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
7 January 2011
Related Shares:
Glaxosmithkline